Y Intercept Hong Kong Ltd bought a new position in DocuSign, Inc. (NASDAQ:DOCU - Free Report) during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor bought 47,957 shares of the company's stock, valued at approximately $2,978,000.
Several other large investors have also recently bought and sold shares of DOCU. Diversified Trust Co raised its stake in DocuSign by 17.7% in the second quarter. Diversified Trust Co now owns 13,133 shares of the company's stock valued at $703,000 after purchasing an additional 1,979 shares in the last quarter. Wealth Enhancement Advisory Services LLC lifted its holdings in shares of DocuSign by 55.3% during the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 8,213 shares of the company's stock worth $439,000 after acquiring an additional 2,925 shares during the last quarter. V Square Quantitative Management LLC lifted its holdings in shares of DocuSign by 25.7% during the 2nd quarter. V Square Quantitative Management LLC now owns 2,847 shares of the company's stock worth $152,000 after acquiring an additional 582 shares during the last quarter. PGGM Investments grew its position in DocuSign by 36.7% in the second quarter. PGGM Investments now owns 49,812 shares of the company's stock worth $2,665,000 after acquiring an additional 13,379 shares in the last quarter. Finally, Baader Bank Aktiengesellschaft increased its stake in DocuSign by 13.0% in the second quarter. Baader Bank Aktiengesellschaft now owns 17,517 shares of the company's stock valued at $937,000 after acquiring an additional 2,017 shares during the last quarter. 77.64% of the stock is owned by institutional investors.
Analysts Set New Price Targets
DOCU has been the subject of a number of research reports. Bank of America upped their price objective on DocuSign from $60.00 to $68.00 and gave the stock a "neutral" rating in a report on Friday, September 6th. Royal Bank of Canada reiterated a "sector perform" rating and set a $90.00 price target (up from $57.00) on shares of DocuSign in a research report on Friday. JPMorgan Chase & Co. lifted their price target on shares of DocuSign from $50.00 to $70.00 and gave the stock an "underweight" rating in a research note on Tuesday, December 3rd. Needham & Company LLC reaffirmed a "hold" rating on shares of DocuSign in a research note on Friday. Finally, UBS Group lifted their target price on shares of DocuSign from $60.00 to $100.00 and gave the stock a "neutral" rating in a research report on Friday. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $92.45.
Read Our Latest Analysis on DOCU
Insider Activity
In other DocuSign news, CFO Blake Jeffrey Grayson sold 14,036 shares of the firm's stock in a transaction dated Wednesday, September 18th. The shares were sold at an average price of $55.47, for a total value of $778,576.92. Following the completion of the sale, the chief financial officer now directly owns 87,611 shares in the company, valued at $4,859,782.17. This trade represents a 13.81 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CEO Allan C. Thygesen sold 7,763 shares of the company's stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $80.54, for a total value of $625,232.02. Following the transaction, the chief executive officer now owns 100,062 shares in the company, valued at $8,058,993.48. This trade represents a 7.20 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 69,596 shares of company stock valued at $4,441,529. Company insiders own 1.66% of the company's stock.
DocuSign Stock Performance
Shares of NASDAQ DOCU traded down $6.41 during trading hours on Tuesday, hitting $95.85. The company's stock had a trading volume of 6,786,668 shares, compared to its average volume of 2,984,491. DocuSign, Inc. has a 12 month low of $48.70 and a 12 month high of $107.86. The stock has a market cap of $19.45 billion, a price-to-earnings ratio of 19.76, a P/E/G ratio of 11.08 and a beta of 0.92. The business has a 50-day simple moving average of $75.46 and a 200-day simple moving average of $62.36.
About DocuSign
(
Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Recommended Stories
Before you consider DocuSign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.
While DocuSign currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.